Oncotarget

Vol 11, No 8

February 25, 2020

View Archive »

Order a Reprint

About The Cover

The cover for issue 8 of Oncotarget features Figure 8, "MLN4924 treatment induces DNA damage by stabilizing CDT1 and accumulates the cells in S phase which are enhanced by MLN4924/cisplatin co-treatment," by Misra, et al.

Table of Contents

Research Papers

EB1-dependent long survival of glioblastoma-grafted mice with the oral tubulin-binder BAL101553 is associated with inhibition of tumor angiogenesis

EB1-dependent long survival of glioblastoma-grafted mice with the oral tubulin-binder BAL101553 is associated with inhibition of tumor angiogenesis

https://doi.org/10.18632/oncotarget.27374

Raphaël Bergès, Aurélie Tchoghandjian, Arnauld Sergé, Stéphane Honoré, Dominique Figarella-Branger, Felix Bachmann, Heidi A. Lane,  and Diane Braguer
759-774
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Press Release  |  Order a Reprint

Subcellular localization of FANCD2 is associated with survival in ovarian carcinoma

Subcellular localization of FANCD2 is associated with survival in ovarian carcinoma

https://doi.org/10.18632/oncotarget.27437

Sonali Joshi, Shawn Campbell, Jeong Y. Lim, Shannon McWeeney, Adam Krieg, Yukie Bean, Nadja Pejovic, Paulette Mhawech-Fauceglia,  and Tanja Pejovic
775-783
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Press Release  |  Order a Reprint

Both BRCA1-wild type and -mutant triple-negative breast cancers show sensitivity to the NAE inhibitor MLN4924 which is enhanced upon MLN4924 and cisplatin combination treatment

Both BRCA1-wild type and -mutant triple-negative breast cancers show sensitivity to the NAE inhibitor MLN4924 which is enhanced upon MLN4924 and cisplatin combination treatment

https://doi.org/10.18632/oncotarget.27485

Shrilekha Misra, Xiaoli Zhang, Nissar Ahmad Wani, Steven Sizemore,  and Alo Ray
784-800
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Press Release  |  Order a Reprint

SLC25A32 sustains cancer cell proliferation by regulating flavin adenine nucleotide (FAD) metabolism

SLC25A32 sustains cancer cell proliferation by regulating flavin adenine nucleotide (FAD) metabolism

https://doi.org/10.18632/oncotarget.27486

Valeria Santoro, Ilya Kovalenko, Kim Vriens, Stefan Christen, Andreas Bernthaler, Andrea Haegebarth, Sarah-Maria Fendt,  and Sven Christian
801-812
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Press Release  |  Order a Reprint

Prolyl 4-hydroxylase alpha 1 protein expression risk-stratifies early stage colorectal cancer

Prolyl 4-hydroxylase alpha 1 protein expression risk-stratifies early stage colorectal cancer

https://doi.org/10.18632/oncotarget.27491

Atsushi Tanaka, Yihua Zhou, Jinru Shia, Fiona Ginty, Makiko Ogawa, David S. Klimstra, Ronald C. Hendrickson, Julia Y. Wang,  and Michael H. Roehrl
813-824
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Press Release  |  Video Interview  |  Order a Reprint

Corrections

Correction: High expression of CTHRC1 promotes EMT of epithelial ovarian cancer (EOC) and is associated with poor prognosis

Correction: High expression of CTHRC1 promotes EMT of epithelial ovarian cancer (EOC) and is associated with poor prognosis

https://doi.org/10.18632/oncotarget.27370

Minzhi Hou, Zhiqiang Cheng, Hongwei Shen, Shanyang He, Yang Li, Yunping Pan, Chongjin Feng, Xinlin Chen, Yang Zhang, Millicent Lin, Liantang Wang,  and Zunfu Ke
825-826
Correction  |  PDF  |  How to cite

Correction: Glioblastoma and glioblastoma stem cells are dependent on functional MTH1

Correction: Glioblastoma and glioblastoma stem cells are dependent on functional MTH1

https://doi.org/10.18632/oncotarget.27484

Linda Pudelko, Pegah Rouhi, Kumar Sanjiv, Helge Gad, Christina Kalderén, Andreas Höglund, Massimo Squatrito, Alberto J. Schuhmacher, Steven Edwards, Daniel Hägerstrand, Ulrika Warpman Berglund, Thomas Helleday,  and Lars Bräutigam
827-827
Correction  |  PDF  |  How to cite


Copyright © 2021 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC